"Among doctors, there's "a strong consensus that Tecfidera offers a more favorable clinical profile than other oral or injectable first-line options," says an analyst. Indeed, some patients have reportedly been waiting for Tecfidera's FDA approval, which came yesterday, before starting any kind of MS treatment"










